NEW YORK (GenomeWeb) – Empire Genomics announced today that it has partnered with Kromatid to develop tools to help researchers detect and understand genomic structural variations of cancer patients.

The companies will combine Empire's next-generations sequencing services, FISH probe portfolio, and CLIA-certified laboratory with Kromatid's Pinpoint probes and new directional genomic hybridization technology — a tool capable of detecting and visualizing structural variations as low as 3Kb at the single-cell level.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.